SlideShare a Scribd company logo
SCREENING OF
ANALGESICS
Prepared by: ASMA M A
First M. Pharm Pharmacology
INTRODUCTION
• Pain is an unpleasant sensory and emotional experience
associated with actual and potential tissue damage.
• Various types of pains seen in humans are:
• Somatic pain (arising from skin, muscles, joints, ligaments
and bones)
• Visceral pain
• Referred pain
• Neuropathic pain
• Cancer pain etc.
• The pain sensing neurons “nociceptors” are stimulated
by physical (heat, cold and pressure) and chemical
stimuli.
• Pain can be classified as acute or chronic,
• Acute pain: it is of soft tissue damage, infection or
inflammation and will be short of duration.
• Chronic pain: it lasts for 6 months or larger than that
period (E.g. cancer pain, neuropathic pain and arthritic
pain).
• Analgesics may be Narcotic or Non-narcotic.
Narcotic Analgesics Non-Narcotic Analgesics
Act centrally Act peripherally
Cause addiction Do not cause addiction
Produce CNS depression Do not produce CNS
depression
Do not produce gastric
irritation
Produce gastric irritation
Show no anti-inflammatory
effect
Show anti-inflammatory
effect
e.g. Morphine, Tramadol
Pethidine etc.
e.g. Diclofenac, Ibuprofen,
Aspirin etc.
SCREENING METHODS
• Screening of analgesic agents include -
• IN-VIVO METHOD
A) Pain-state models using Thermal stimuli
i. The tail-flick model using radiant heat/ Immersion of
the tail in hot water.
ii. Paw-withdrawal test.
iii. Hot-plate test.
iv. Pain-state models using Cold- stimuli
B) Pain-state models using Mechanical stimuli
i. Strain gauges.
ii. Von-Frey filaments.
iii. Inclined-plane test.
C) Pain-state models using Electrical stimuli
i. Electrical stimulation of the tail.
ii. Grid-shock test.
iii. Stimulation of the tooth pulp.
iv. Monkey-shock titration test.
v. Stimulation of the limbs.
D) Pain-state models using Chemical stimuli
i. Formalin test.
ii. Acetic acid induced writhing test.
iii. Stimulation of hollow organs.
• IN-VITRO METHOD
A. Bioassay of nociceptin.
B. Recetptor binding of nociceptin.
C. 3H- naloxone binding assay.
D. 3H- bremazocine binding assay.
E. Cannabinoids binding assay.
F. Inhibition of Enkephalinase.
PAIN-STATE MODELS USING THERMAL STIMULI
1. THE TAIL-FLICK MODELS (using radiant heat)
AIM
• Tail flick method is widely and reliably used for the testing
of opioid analgesics.
REQUIREMENTS
Animals required: Albino mice (18-22g)
Chemicals required: Test compound
Equipment required: cages leaving tail exposed out
PRINCIPLE AND ROCEDURE
• The application of thermal radiation to the tail of an
animal provokes the withdrawal of the tail by a brief
vigorous movement.
• The withdraw of the tail from the heat source is referred
to as tail-flick latency.
• In this model a timer is started at the same time as the
application of the heat source and time taken by the rat
to withdraw its tail is recorded.
• Usually withdrawal time is within 2 to 10s.
• The lengthening of this reaction time by the animal seen
after the administration of a drug is interpreted as an
analgesic action.
• It is advisable not to prolong the exposure to radiant heat
beyond 20s because the skin of the tail may be burnt.
• A rheostat is inserted in the apparatus so as to control the
intensity of the current passing through the filament,
which further controls the intensity of radiant heat.
• This test is more sensitive to morphine.
EVALUATION
• At each time interval those animals that show higher
reaction time than the time before drug administration
are regarded as positive.
• Percentage of positive animals are counted for each time
interval and each dose and ED50 values of test compound
can be calculated
MERITS
• This method is very effective for screening morphine- like
analgesics.
• The technique is simple and does not require any special skill.
• The results of experiments are quite accurate and less time
consuming.
DEMERITS
• The tail-flick response is prone to habituation.
• The tail- flick response is not consistent upon repetitive
stimulation.
• Habituation is observed with a shortening of the inter-
stimulus interval and increased intensity of heat.
• This test is truly efficient only for revealing the activity of
opioid analgesics (but not of opioid partial agonists.
2. HOT PLATE MODEL
AIM
• Hot plate method has been widely used to evaluate opioid
analgesics.
REQUIREMENTS
Animals required: Albino mice
Chemicals required: Test compound
Equipment requirement: Hot plate at 55-66 C
(electrically heated late)
PRINCIPLE AND ROCEDURE
• This test consists of introducing a rat or mouse into an
open-ended cylindrical space with a floor consisting of a
metallic plate that is heated by a thermode or a boiling
liquid.
• A plate heated to a constant temperature produces two
behavioural components that can be measured in terms of
their reaction times, namely paw licking and jumping.
• Animals are placed on the hot plate, which consist of
electrically heated surface.
• Temperature on the hot plate is maintained at 55-56 degree
celcius.
• Responses such as jumping ,withdrawal of the paws and
licking of the paws are seen.
• Both are considered to be supra-spinally integrated
responses.
• The time period (latency period), when animals are placed
and until responses occur, is recorded by a stopwatch.
• After administration of analgesic substances, the paw
licking behavior time and the jumping reaction time is
increased.
EVALUATION
• Test compounds are administered orally or subcutaneously
and latency or latency period is recorded after 20,60.90
min.
• These values are compared with the values before
administration of the drug b using T-test.
DEMERIT
• The sedatives, muscle relaxants or psychomimetics
yield false positive results, while partial opiate agonist-
antagonists produce unreliable results.
PAIN- STATE MODELS USING ELECTRICAL STIMULI
3. TOOTH PULP TEST
AIM
• This test is used of the screening of analgesics using electrical
stimuli.
REQUIREMENTS
Animals required: Rabbits (2-3 kg)
Chemicals required: Thiopental(15 mg /kg)
Equipment required: Dental drill tooth pulp,
clamping electrodes
PRINCIPLE AND PROCEDURE
• This method is based on the stimulation of the tooth-pulp of
the animal by applying electric current.
• Stimulation of the tooth-pulp produces characteristic
reactions such as licking, biting, chewing and head flick due
to induction of pain, which can be observed easily.
• Rabbits of either sex are anaesthetized with 15 mg/kg
thiopental or 0.2 mg/kg fentanyl-citrate i.v.
• Pulp chambers are exposed close to the gingival line in the
lateral margins of the two front upper incisors with a high-
speed dental drill.
• On the day of the experiment, clamping electrodes are placed
into the drilled holes.
• After an accommodation period of 30min, electrical
stimulation is started to determine the threshold value.
• The stimulus is applied by rectangular current with a
frequency of 50 Hz for duration of 1 s.
• The electrical current is started with 0.2 mA and increased
until the phenomenon of licking occurs.
• In some cases, the current has to be increased and then
decreased again in order to find the appropriate threshold.
EVALUATION
• Test compound is administered orally or i.v .
• After 15,30 60 and 120 min threshold current is measured
and compared with the threshold current prior to drug
administration.
PAIN-STATE MODELS USING CHEMICAL STIMULI
4. ACETIC ACID INDUCED WRITHING TEST
AIM
• This test is used to screen analgesics by using chemical
stimulus.
REQUIREMENTS
Animals required: Albino mice
Chemicals required: Acetic acid 0.7% v/v (1ml/100g)
Aspirin (100mg/kg)
PRINCIPLE AND PROCEDURE
• Pain is often induced in rats or mice by injecting certain
irritants such as phenyl quinone or acetic acid into the
peritoneal cavity.
• The animal reacts with a characteristic stretching behavior
which is called writhing.
• The intra-peritoneal administration of agents that irritate
serous membranes elicits a stereotyped behavior in the
mouse/rat, which is characterized by abdominal
contractions, movements of the body as a whole
(particularly of the hind paws), twisting of dorso-abdominal
muscles, and motor in- coordination.
• Divide the animals into 2 groups each consisting of 5
animals.
• The first group serves as control and the second group is
the test group
• Administer the appropriate volume of acetic acid solution to
the first group and place individually under glass jar for
observation.
• Note the onset of writhing and number of writhing for a
period of 10 minutes.
• Administer Aspirin 100mg/kg orally to the second group of
animals and 30 minutes later administer acetic acid solution.
• Note the onset and number of writhing responses.
EVALUATION
• Calculating the mean writhing response of control and test
group.
• From this value the percentage protection of analgesics can
be calculated.
INVITRO METHOD
1. BIOASSAY OF NOCICEPTIN
AIM
• Nociceptin receptors in the periphery can be characterized
by studies in isolated organs such as the guinea pig ileum,
the mouse vas deferens, the rabbit vas deferens, the guinea
pig renal pelvis.
REQUIREMENTS
Tissue : Guinea pig ileum, mouse vas deferens, rabbit vas
deferens, guinea pig renal pelvis.
Physiological salt solution: Kreb’s solution.
PROCEDURE
• Take the tissues from male Swiss mice, guinea pigs,
Sprague Dawley rats & New Zealand albino rabbit.
• Suspend in 10 ml organ baths containing Krebs solution
oxygenated with 95% O2 & 5% CO2.
• Set the temperature around 33°-37°C & apply 0.3-1g of
resting tension.
• Stimulate the tissue with two platinum ring electrodes.
• Measure the electrically evoked contractions isotonically
with a strain gauge transducer and record on a
multichannel chart recorder.
• After equilibration period of about 60 min the contractions
induced by electrical field stimulation become stable; at this
time, perform the cumulative concentration response
curves to nociceptin or opioid peptides.
• Perform four electrical field stimulation with each tissue at
30 min intervals.
• Add Agonists & Antagonists to the bath.
• The biological effects of the application of agonists or
antagonists are expressed as % inhibition of electrical filed
stimulation-induced contraction.
• Contractile responses to electrical field stimulation are
expressed as % increment to the spontaneous activity of the
tissue.
EVALUATION
• Data are expressed as means of n experiments and
statistically analyzed and recorded.
2. 3H- NALOXONE BINDING ASSAY
AIM
This test is used for the study of opiate agonist and antagonist.
REQUIREMENTS
Animal required: Wistar rat
Physiological salt solution: Tris buffer
PROCEDURE
• Decapitate the male Wistar rat and rapidly remove their
brain.
• Weigh whole brain except cerebella and homogenize in
50ml of 0.05M Tris buffer with a Tekmar tissue
homogenizer.
• Centrifuge the homogenate for 15 minutes, decant the
supernatant and re-suspend the pellet in fresh buffer and
centrifuge.
• Then suspend the final pellet in original volume of fresh
0.05M Tris buffer.
• Incubate the tubes for 30 minutes at 37 degree Celsius.
• The assay is stopped by vacuum filtration through
Whatman GF filters which are then washed three times
with ice-cold 0.05M Tris buffer of pH 7.7.
• The filters are then counted in 10ml of Liquiscint liquid
scintillation cocktail.
• Stereospecific binding is defined as the difference
between binding in presence of 0.1μM dextrorphan and
0.1μM levorphanol.
EVALUATION
• Data are converted into % stereospecific naloxone
binding displaced by the test drug.
• Data can be analyzed by using a computer program as
described by McPherson in 1985.
3. INHIBITION OF ENKEPHALINASE
AIM
• It is found that the enkephalinase inhibitor thiorphan
shows anti-nociceptive activity in mice.
• So inhibition of enkephalinase is used as the invitro
method for the screening of analgesics.
REQUIREMENTS
Animal required: Rat
Physiological salt solution: Tris-HCl buffer
PROCEDURE
• Fresh rat kidney is homogenized in 10 vol of cold 0.05M
Tris-HCl buffer of pH 7.4 using a Polytron homogenizer.
• The homogenate is centrifuged for 5 minutes.
• The pellet is discarded and the supernatant centrifuged for
60 minutes.
• The resulting pellet is resuspended in 50mM Tris-HCl
buffer and used as the enzyme source .
• The assay is carried at 37 C in hemolysis tubes.
• A 0.1ml amount of 50mM Tris-HCl buffer is preincubated
15 minutes at 37 C.
• The reaction is initiated by addition of 50μl of the enzyme
preparation together with 0.5 μM Captopril.
• The tubes are incubated for 30 minutes in a water bath
with constant shaking
• The enzymatic reaction is stopped by boiling at 100 C for
5 minutes.
• The samples are then diluted with 1.35ml of Tris-HCl
buffer and centrifuged for 30 minutes.
• 1ml of supernatant is transferred to thermostat cells of a
spectrofluorometer.
• Reading are performed at 562nm with an excitation
wavelength of 342nm.
• A calibration curve is prepared.
EVALUATION
• The inhibitory potencies of test compounds are compared
with the standard.

More Related Content

What's hot

Cns stimulants and depressants screening models
Cns stimulants and depressants screening modelsCns stimulants and depressants screening models
Cns stimulants and depressants screening models
DRASHTI PATEL
 
screening methods for Antiepileptic activity
screening methods for Antiepileptic activityscreening methods for Antiepileptic activity
screening methods for Antiepileptic activitySravanthi Shetty
 
Hepatoprotective screening methods
Hepatoprotective screening methodsHepatoprotective screening methods
Hepatoprotective screening methods
ShobhiniChandel
 
Screening of analgesics
Screening of analgesicsScreening of analgesics
Screening of analgesics
Dr. Irfan Ahmad Khan
 
Screening of antiepileptic drugs
Screening of antiepileptic drugsScreening of antiepileptic drugs
Screening of antiepileptic drugs
Kanthlal SK
 
SCREENING OF ANALGESICS & ANTIPYRETIC
SCREENING  OF  ANALGESICS & ANTIPYRETICSCREENING  OF  ANALGESICS & ANTIPYRETIC
SCREENING OF ANALGESICS & ANTIPYRETIC
Pranesh Kumar
 
Screening of antiparkinsonian agents
Screening of antiparkinsonian agentsScreening of antiparkinsonian agents
Screening of antiparkinsonian agents
Dr. Mallappa Shalavadi
 
Screening models for inflammatory drugs
Screening models for inflammatory drugsScreening models for inflammatory drugs
Screening models for inflammatory drugs
My_VivJaan
 
Screening models of antiepileptic and nootropic drugs
Screening models of antiepileptic and nootropic drugsScreening models of antiepileptic and nootropic drugs
Screening models of antiepileptic and nootropic drugs
HimikaRathi
 
Screening of Anxiolytics
Screening of AnxiolyticsScreening of Anxiolytics
Screening of Anxiolytics
Dr. Advaitha MV
 
Screening of antipyretic drugs
Screening of antipyretic drugsScreening of antipyretic drugs
Screening of antipyretic drugs
drarunsingh4
 
Screening of antipyretic drugs
Screening of antipyretic drugsScreening of antipyretic drugs
Screening of antipyretic drugs
Sindhoora Shetty
 
Antipsychotic screening- Dr Divya Krishnan
Antipsychotic screening- Dr Divya Krishnan Antipsychotic screening- Dr Divya Krishnan
Antipsychotic screening- Dr Divya Krishnan Divya Krishnan
 
Screening of anti alzheimers
Screening of anti alzheimersScreening of anti alzheimers
Screening of anti alzheimers
Dr Roohana Hasan
 
Screening of anti anxiety drugs
Screening of anti anxiety drugsScreening of anti anxiety drugs
Screening of anti anxiety drugsBindu Pulugurtha
 
Anti epileptic screening model
Anti epileptic screening modelAnti epileptic screening model
Anti epileptic screening model
KhushbooThakur15
 
Screening antianginal (1)
Screening antianginal (1)Screening antianginal (1)
Screening antianginal (1)
Dr Roohana Hasan
 
Screening models(IN-VIVO) for analgesics and anti inflammatory agents
Screening models(IN-VIVO) for analgesics and anti inflammatory agentsScreening models(IN-VIVO) for analgesics and anti inflammatory agents
Screening models(IN-VIVO) for analgesics and anti inflammatory agents
MADHAV JAJNURE
 
Screening models of Anti diabetics.
Screening models of Anti diabetics.Screening models of Anti diabetics.
Screening of antihypertensive agents
Screening of antihypertensive agentsScreening of antihypertensive agents
Screening of antihypertensive agentsKanthlal SK
 

What's hot (20)

Cns stimulants and depressants screening models
Cns stimulants and depressants screening modelsCns stimulants and depressants screening models
Cns stimulants and depressants screening models
 
screening methods for Antiepileptic activity
screening methods for Antiepileptic activityscreening methods for Antiepileptic activity
screening methods for Antiepileptic activity
 
Hepatoprotective screening methods
Hepatoprotective screening methodsHepatoprotective screening methods
Hepatoprotective screening methods
 
Screening of analgesics
Screening of analgesicsScreening of analgesics
Screening of analgesics
 
Screening of antiepileptic drugs
Screening of antiepileptic drugsScreening of antiepileptic drugs
Screening of antiepileptic drugs
 
SCREENING OF ANALGESICS & ANTIPYRETIC
SCREENING  OF  ANALGESICS & ANTIPYRETICSCREENING  OF  ANALGESICS & ANTIPYRETIC
SCREENING OF ANALGESICS & ANTIPYRETIC
 
Screening of antiparkinsonian agents
Screening of antiparkinsonian agentsScreening of antiparkinsonian agents
Screening of antiparkinsonian agents
 
Screening models for inflammatory drugs
Screening models for inflammatory drugsScreening models for inflammatory drugs
Screening models for inflammatory drugs
 
Screening models of antiepileptic and nootropic drugs
Screening models of antiepileptic and nootropic drugsScreening models of antiepileptic and nootropic drugs
Screening models of antiepileptic and nootropic drugs
 
Screening of Anxiolytics
Screening of AnxiolyticsScreening of Anxiolytics
Screening of Anxiolytics
 
Screening of antipyretic drugs
Screening of antipyretic drugsScreening of antipyretic drugs
Screening of antipyretic drugs
 
Screening of antipyretic drugs
Screening of antipyretic drugsScreening of antipyretic drugs
Screening of antipyretic drugs
 
Antipsychotic screening- Dr Divya Krishnan
Antipsychotic screening- Dr Divya Krishnan Antipsychotic screening- Dr Divya Krishnan
Antipsychotic screening- Dr Divya Krishnan
 
Screening of anti alzheimers
Screening of anti alzheimersScreening of anti alzheimers
Screening of anti alzheimers
 
Screening of anti anxiety drugs
Screening of anti anxiety drugsScreening of anti anxiety drugs
Screening of anti anxiety drugs
 
Anti epileptic screening model
Anti epileptic screening modelAnti epileptic screening model
Anti epileptic screening model
 
Screening antianginal (1)
Screening antianginal (1)Screening antianginal (1)
Screening antianginal (1)
 
Screening models(IN-VIVO) for analgesics and anti inflammatory agents
Screening models(IN-VIVO) for analgesics and anti inflammatory agentsScreening models(IN-VIVO) for analgesics and anti inflammatory agents
Screening models(IN-VIVO) for analgesics and anti inflammatory agents
 
Screening models of Anti diabetics.
Screening models of Anti diabetics.Screening models of Anti diabetics.
Screening models of Anti diabetics.
 
Screening of antihypertensive agents
Screening of antihypertensive agentsScreening of antihypertensive agents
Screening of antihypertensive agents
 

Viewers also liked

Narcotic and Non Narcotic Analgesics
Narcotic and Non Narcotic AnalgesicsNarcotic and Non Narcotic Analgesics
Narcotic and Non Narcotic Analgesics
Amit Sinha
 
Seadtion and pain control warwick 18 nov-11-1
Seadtion and pain control warwick 18 nov-11-1Seadtion and pain control warwick 18 nov-11-1
Seadtion and pain control warwick 18 nov-11-1Iyad Abou Rabii
 
seminar analgesics
seminar analgesicsseminar analgesics
seminar analgesics
Rajesh Sardana
 
NSAIDS
NSAIDSNSAIDS
NSAIDS
Shaik Sana
 
Analgesics general dentistry /certified fixed orthodontic courses by Indian d...
Analgesics general dentistry /certified fixed orthodontic courses by Indian d...Analgesics general dentistry /certified fixed orthodontic courses by Indian d...
Analgesics general dentistry /certified fixed orthodontic courses by Indian d...
Indian dental academy
 
Anagesics in dentistry /prosthodontic courses
Anagesics in dentistry /prosthodontic coursesAnagesics in dentistry /prosthodontic courses
Anagesics in dentistry /prosthodontic courses
Indian dental academy
 
Analgesics in oral surgery
Analgesics in oral surgeryAnalgesics in oral surgery
Analgesics in oral surgery
Indian dental academy
 
Central analgesics and Non-steroidal ant-iinflammatory agents
Central analgesics and Non-steroidal ant-iinflammatory agentsCentral analgesics and Non-steroidal ant-iinflammatory agents
Central analgesics and Non-steroidal ant-iinflammatory agents
Dr. Ravi Sankar
 
Analgesics and anti inflammatory drugs
Analgesics and anti inflammatory drugsAnalgesics and anti inflammatory drugs
Analgesics and anti inflammatory drugs
Bhaumik Thakkar
 
Analgesics for Oral Surgery
Analgesics for Oral SurgeryAnalgesics for Oral Surgery
Analgesics for Oral Surgery
IAU Dent
 
Analgesics
AnalgesicsAnalgesics
Analgesics
alishahsavan20
 
Analgesics in dentistry
Analgesics in dentistryAnalgesics in dentistry
Analgesics in dentistry
Medicinist
 
Analgesics in maxillofacial surgery by Dr. Amit Suryawanshi .Oral & Maxillo...
Analgesics in maxillofacial surgery  by  Dr. Amit Suryawanshi .Oral & Maxillo...Analgesics in maxillofacial surgery  by  Dr. Amit Suryawanshi .Oral & Maxillo...
Analgesics in maxillofacial surgery by Dr. Amit Suryawanshi .Oral & Maxillo...
All Good Things
 
Analgesics
AnalgesicsAnalgesics
AnalgesicsAnan
 
analgesics and dentistry
analgesics and dentistryanalgesics and dentistry
analgesics and dentistry
Mehul Shinde
 
Analgesic screeening model
Analgesic screeening modelAnalgesic screeening model
Analgesic screeening model
Chaitra Nagaraj
 
Therapeutics in dentistry(analgesics)
Therapeutics in dentistry(analgesics)Therapeutics in dentistry(analgesics)
Therapeutics in dentistry(analgesics)Iyad Abou Rabii
 

Viewers also liked (20)

Narcotic and Non Narcotic Analgesics
Narcotic and Non Narcotic AnalgesicsNarcotic and Non Narcotic Analgesics
Narcotic and Non Narcotic Analgesics
 
Analgesics
AnalgesicsAnalgesics
Analgesics
 
Seadtion and pain control warwick 18 nov-11-1
Seadtion and pain control warwick 18 nov-11-1Seadtion and pain control warwick 18 nov-11-1
Seadtion and pain control warwick 18 nov-11-1
 
seminar analgesics
seminar analgesicsseminar analgesics
seminar analgesics
 
NSAIDS
NSAIDSNSAIDS
NSAIDS
 
Analgesics general dentistry /certified fixed orthodontic courses by Indian d...
Analgesics general dentistry /certified fixed orthodontic courses by Indian d...Analgesics general dentistry /certified fixed orthodontic courses by Indian d...
Analgesics general dentistry /certified fixed orthodontic courses by Indian d...
 
Anagesics in dentistry /prosthodontic courses
Anagesics in dentistry /prosthodontic coursesAnagesics in dentistry /prosthodontic courses
Anagesics in dentistry /prosthodontic courses
 
Analgesics in oral surgery
Analgesics in oral surgeryAnalgesics in oral surgery
Analgesics in oral surgery
 
Analgesics
AnalgesicsAnalgesics
Analgesics
 
Central analgesics and Non-steroidal ant-iinflammatory agents
Central analgesics and Non-steroidal ant-iinflammatory agentsCentral analgesics and Non-steroidal ant-iinflammatory agents
Central analgesics and Non-steroidal ant-iinflammatory agents
 
Analgesics and anti inflammatory drugs
Analgesics and anti inflammatory drugsAnalgesics and anti inflammatory drugs
Analgesics and anti inflammatory drugs
 
Analgesics
AnalgesicsAnalgesics
Analgesics
 
Analgesics for Oral Surgery
Analgesics for Oral SurgeryAnalgesics for Oral Surgery
Analgesics for Oral Surgery
 
Analgesics
AnalgesicsAnalgesics
Analgesics
 
Analgesics in dentistry
Analgesics in dentistryAnalgesics in dentistry
Analgesics in dentistry
 
Analgesics in maxillofacial surgery by Dr. Amit Suryawanshi .Oral & Maxillo...
Analgesics in maxillofacial surgery  by  Dr. Amit Suryawanshi .Oral & Maxillo...Analgesics in maxillofacial surgery  by  Dr. Amit Suryawanshi .Oral & Maxillo...
Analgesics in maxillofacial surgery by Dr. Amit Suryawanshi .Oral & Maxillo...
 
Analgesics
AnalgesicsAnalgesics
Analgesics
 
analgesics and dentistry
analgesics and dentistryanalgesics and dentistry
analgesics and dentistry
 
Analgesic screeening model
Analgesic screeening modelAnalgesic screeening model
Analgesic screeening model
 
Therapeutics in dentistry(analgesics)
Therapeutics in dentistry(analgesics)Therapeutics in dentistry(analgesics)
Therapeutics in dentistry(analgesics)
 

Similar to Screening of analgesics

Screening methods for Analgesics
Screening methods for AnalgesicsScreening methods for Analgesics
Screening methods for Analgesics
FoziyaKhan
 
Analgesic Screening Models
Analgesic Screening ModelsAnalgesic Screening Models
Analgesic Screening Models
MadhurimaSahay
 
antiinflammatory drugs ppt..............
antiinflammatory drugs ppt..............antiinflammatory drugs ppt..............
antiinflammatory drugs ppt..............
MsSapnaSapna
 
ANALGESIC MODELS
ANALGESIC MODELSANALGESIC MODELS
ANALGESIC MODELS
Puneshwar Keshari
 
Analgesic models
Analgesic modelsAnalgesic models
Analgesic models
Puneshwar Keshari
 
Screening models diuretics and analgesics
Screening models diuretics and analgesicsScreening models diuretics and analgesics
Screening models diuretics and analgesics
RohitPal122
 
Preclinical Models for Analgesic Drugs.pptx
Preclinical Models for Analgesic Drugs.pptxPreclinical Models for Analgesic Drugs.pptx
Preclinical Models for Analgesic Drugs.pptx
Renuka N Sunagad
 
preclinical screening models for Analgesic drugs
preclinical screening models for Analgesic drugs preclinical screening models for Analgesic drugs
preclinical screening models for Analgesic drugs
SachinGulia12
 
Screening Methods of Analgesics Agents...
Screening Methods of Analgesics Agents...Screening Methods of Analgesics Agents...
Screening Methods of Analgesics Agents...
A. Gowtham Sashtha
 
Preclinical Screening of drugs.pptx
Preclinical Screening of drugs.pptxPreclinical Screening of drugs.pptx
Preclinical Screening of drugs.pptx
hrutujarane
 
Pharmacological screening of analgesic activity
Pharmacological screening of analgesic activityPharmacological screening of analgesic activity
Pharmacological screening of analgesic activity
Biswash Sapkota
 
Hypnotics Screening Methods by Tarun Biswas
Hypnotics Screening Methods by Tarun BiswasHypnotics Screening Methods by Tarun Biswas
Hypnotics Screening Methods by Tarun Biswas
Tarun Biswas
 
Screening methods of immunomodulators by shivam diwaker
Screening methods of immunomodulators by shivam diwakerScreening methods of immunomodulators by shivam diwaker
Screening methods of immunomodulators by shivam diwaker
Shivam Diwaker
 
Screening of antidepressant
Screening of antidepressantScreening of antidepressant
Screening of antidepressant
Sharawat123
 
Analgesics.pptx
Analgesics.pptxAnalgesics.pptx
Analgesics.pptx
KiranChoudhari6
 
Screening of Analgesic Drugs pHARMACOLOGY.pptx
Screening of Analgesic Drugs pHARMACOLOGY.pptxScreening of Analgesic Drugs pHARMACOLOGY.pptx
Screening of Analgesic Drugs pHARMACOLOGY.pptx
DrDeveshPandey1
 
reptile anaesthesia
reptile anaesthesiareptile anaesthesia
reptile anaesthesia
Rubiat Ferdous
 
Antiepileptic drugs screening methods
Antiepileptic drugs screening methodsAntiepileptic drugs screening methods
Antiepileptic drugs screening methods
Koppala RVS Chaitanya
 
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
helasri gummadi
 
Anlalgesic activity and its classification
Anlalgesic activity and its classificationAnlalgesic activity and its classification
Anlalgesic activity and its classification
KOMAL AROOSH
 

Similar to Screening of analgesics (20)

Screening methods for Analgesics
Screening methods for AnalgesicsScreening methods for Analgesics
Screening methods for Analgesics
 
Analgesic Screening Models
Analgesic Screening ModelsAnalgesic Screening Models
Analgesic Screening Models
 
antiinflammatory drugs ppt..............
antiinflammatory drugs ppt..............antiinflammatory drugs ppt..............
antiinflammatory drugs ppt..............
 
ANALGESIC MODELS
ANALGESIC MODELSANALGESIC MODELS
ANALGESIC MODELS
 
Analgesic models
Analgesic modelsAnalgesic models
Analgesic models
 
Screening models diuretics and analgesics
Screening models diuretics and analgesicsScreening models diuretics and analgesics
Screening models diuretics and analgesics
 
Preclinical Models for Analgesic Drugs.pptx
Preclinical Models for Analgesic Drugs.pptxPreclinical Models for Analgesic Drugs.pptx
Preclinical Models for Analgesic Drugs.pptx
 
preclinical screening models for Analgesic drugs
preclinical screening models for Analgesic drugs preclinical screening models for Analgesic drugs
preclinical screening models for Analgesic drugs
 
Screening Methods of Analgesics Agents...
Screening Methods of Analgesics Agents...Screening Methods of Analgesics Agents...
Screening Methods of Analgesics Agents...
 
Preclinical Screening of drugs.pptx
Preclinical Screening of drugs.pptxPreclinical Screening of drugs.pptx
Preclinical Screening of drugs.pptx
 
Pharmacological screening of analgesic activity
Pharmacological screening of analgesic activityPharmacological screening of analgesic activity
Pharmacological screening of analgesic activity
 
Hypnotics Screening Methods by Tarun Biswas
Hypnotics Screening Methods by Tarun BiswasHypnotics Screening Methods by Tarun Biswas
Hypnotics Screening Methods by Tarun Biswas
 
Screening methods of immunomodulators by shivam diwaker
Screening methods of immunomodulators by shivam diwakerScreening methods of immunomodulators by shivam diwaker
Screening methods of immunomodulators by shivam diwaker
 
Screening of antidepressant
Screening of antidepressantScreening of antidepressant
Screening of antidepressant
 
Analgesics.pptx
Analgesics.pptxAnalgesics.pptx
Analgesics.pptx
 
Screening of Analgesic Drugs pHARMACOLOGY.pptx
Screening of Analgesic Drugs pHARMACOLOGY.pptxScreening of Analgesic Drugs pHARMACOLOGY.pptx
Screening of Analgesic Drugs pHARMACOLOGY.pptx
 
reptile anaesthesia
reptile anaesthesiareptile anaesthesia
reptile anaesthesia
 
Antiepileptic drugs screening methods
Antiepileptic drugs screening methodsAntiepileptic drugs screening methods
Antiepileptic drugs screening methods
 
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
 
Anlalgesic activity and its classification
Anlalgesic activity and its classificationAnlalgesic activity and its classification
Anlalgesic activity and its classification
 

More from Asma Ashraf

Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
Pharmacoepidemiology
Asma Ashraf
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
Asma Ashraf
 
Principles and methods of elisa, fpia,
Principles and methods of elisa, fpia,Principles and methods of elisa, fpia,
Principles and methods of elisa, fpia,
Asma Ashraf
 
Screening of drugs used in arthritis
Screening of drugs used in arthritisScreening of drugs used in arthritis
Screening of drugs used in arthritis
Asma Ashraf
 
Nmr spectroscopy
Nmr spectroscopyNmr spectroscopy
Nmr spectroscopy
Asma Ashraf
 
Enzymes involved in dna replication
Enzymes involved in dna replicationEnzymes involved in dna replication
Enzymes involved in dna replication
Asma Ashraf
 
Dna isolation
Dna isolationDna isolation
Dna isolation
Asma Ashraf
 
Infrared spectroscopy
Infrared spectroscopyInfrared spectroscopy
Infrared spectroscopy
Asma Ashraf
 

More from Asma Ashraf (8)

Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
Pharmacoepidemiology
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Principles and methods of elisa, fpia,
Principles and methods of elisa, fpia,Principles and methods of elisa, fpia,
Principles and methods of elisa, fpia,
 
Screening of drugs used in arthritis
Screening of drugs used in arthritisScreening of drugs used in arthritis
Screening of drugs used in arthritis
 
Nmr spectroscopy
Nmr spectroscopyNmr spectroscopy
Nmr spectroscopy
 
Enzymes involved in dna replication
Enzymes involved in dna replicationEnzymes involved in dna replication
Enzymes involved in dna replication
 
Dna isolation
Dna isolationDna isolation
Dna isolation
 
Infrared spectroscopy
Infrared spectroscopyInfrared spectroscopy
Infrared spectroscopy
 

Recently uploaded

Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
RaedMohamed3
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
vaibhavrinwa19
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
CarlosHernanMontoyab2
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
Jheel Barad
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
Celine George
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
Balvir Singh
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
Jean Carlos Nunes Paixão
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
EverAndrsGuerraGuerr
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
Peter Windle
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Levi Shapiro
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Po-Chuan Chen
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Atul Kumar Singh
 

Recently uploaded (20)

Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
 

Screening of analgesics

  • 1. SCREENING OF ANALGESICS Prepared by: ASMA M A First M. Pharm Pharmacology
  • 2. INTRODUCTION • Pain is an unpleasant sensory and emotional experience associated with actual and potential tissue damage. • Various types of pains seen in humans are: • Somatic pain (arising from skin, muscles, joints, ligaments and bones) • Visceral pain • Referred pain • Neuropathic pain • Cancer pain etc.
  • 3. • The pain sensing neurons “nociceptors” are stimulated by physical (heat, cold and pressure) and chemical stimuli. • Pain can be classified as acute or chronic, • Acute pain: it is of soft tissue damage, infection or inflammation and will be short of duration. • Chronic pain: it lasts for 6 months or larger than that period (E.g. cancer pain, neuropathic pain and arthritic pain). • Analgesics may be Narcotic or Non-narcotic.
  • 4. Narcotic Analgesics Non-Narcotic Analgesics Act centrally Act peripherally Cause addiction Do not cause addiction Produce CNS depression Do not produce CNS depression Do not produce gastric irritation Produce gastric irritation Show no anti-inflammatory effect Show anti-inflammatory effect e.g. Morphine, Tramadol Pethidine etc. e.g. Diclofenac, Ibuprofen, Aspirin etc.
  • 5. SCREENING METHODS • Screening of analgesic agents include - • IN-VIVO METHOD A) Pain-state models using Thermal stimuli i. The tail-flick model using radiant heat/ Immersion of the tail in hot water. ii. Paw-withdrawal test. iii. Hot-plate test. iv. Pain-state models using Cold- stimuli
  • 6. B) Pain-state models using Mechanical stimuli i. Strain gauges. ii. Von-Frey filaments. iii. Inclined-plane test. C) Pain-state models using Electrical stimuli i. Electrical stimulation of the tail. ii. Grid-shock test. iii. Stimulation of the tooth pulp. iv. Monkey-shock titration test. v. Stimulation of the limbs.
  • 7. D) Pain-state models using Chemical stimuli i. Formalin test. ii. Acetic acid induced writhing test. iii. Stimulation of hollow organs. • IN-VITRO METHOD A. Bioassay of nociceptin. B. Recetptor binding of nociceptin. C. 3H- naloxone binding assay. D. 3H- bremazocine binding assay. E. Cannabinoids binding assay. F. Inhibition of Enkephalinase.
  • 8. PAIN-STATE MODELS USING THERMAL STIMULI 1. THE TAIL-FLICK MODELS (using radiant heat) AIM • Tail flick method is widely and reliably used for the testing of opioid analgesics. REQUIREMENTS Animals required: Albino mice (18-22g) Chemicals required: Test compound Equipment required: cages leaving tail exposed out
  • 9.
  • 10. PRINCIPLE AND ROCEDURE • The application of thermal radiation to the tail of an animal provokes the withdrawal of the tail by a brief vigorous movement. • The withdraw of the tail from the heat source is referred to as tail-flick latency. • In this model a timer is started at the same time as the application of the heat source and time taken by the rat to withdraw its tail is recorded. • Usually withdrawal time is within 2 to 10s. • The lengthening of this reaction time by the animal seen after the administration of a drug is interpreted as an analgesic action.
  • 11. • It is advisable not to prolong the exposure to radiant heat beyond 20s because the skin of the tail may be burnt. • A rheostat is inserted in the apparatus so as to control the intensity of the current passing through the filament, which further controls the intensity of radiant heat. • This test is more sensitive to morphine. EVALUATION • At each time interval those animals that show higher reaction time than the time before drug administration are regarded as positive. • Percentage of positive animals are counted for each time interval and each dose and ED50 values of test compound can be calculated
  • 12. MERITS • This method is very effective for screening morphine- like analgesics. • The technique is simple and does not require any special skill. • The results of experiments are quite accurate and less time consuming. DEMERITS • The tail-flick response is prone to habituation. • The tail- flick response is not consistent upon repetitive stimulation. • Habituation is observed with a shortening of the inter- stimulus interval and increased intensity of heat. • This test is truly efficient only for revealing the activity of opioid analgesics (but not of opioid partial agonists.
  • 13. 2. HOT PLATE MODEL AIM • Hot plate method has been widely used to evaluate opioid analgesics. REQUIREMENTS Animals required: Albino mice Chemicals required: Test compound Equipment requirement: Hot plate at 55-66 C (electrically heated late)
  • 14.
  • 15. PRINCIPLE AND ROCEDURE • This test consists of introducing a rat or mouse into an open-ended cylindrical space with a floor consisting of a metallic plate that is heated by a thermode or a boiling liquid. • A plate heated to a constant temperature produces two behavioural components that can be measured in terms of their reaction times, namely paw licking and jumping. • Animals are placed on the hot plate, which consist of electrically heated surface. • Temperature on the hot plate is maintained at 55-56 degree celcius. • Responses such as jumping ,withdrawal of the paws and licking of the paws are seen.
  • 16. • Both are considered to be supra-spinally integrated responses. • The time period (latency period), when animals are placed and until responses occur, is recorded by a stopwatch. • After administration of analgesic substances, the paw licking behavior time and the jumping reaction time is increased. EVALUATION • Test compounds are administered orally or subcutaneously and latency or latency period is recorded after 20,60.90 min. • These values are compared with the values before administration of the drug b using T-test.
  • 17. DEMERIT • The sedatives, muscle relaxants or psychomimetics yield false positive results, while partial opiate agonist- antagonists produce unreliable results.
  • 18. PAIN- STATE MODELS USING ELECTRICAL STIMULI 3. TOOTH PULP TEST AIM • This test is used of the screening of analgesics using electrical stimuli. REQUIREMENTS Animals required: Rabbits (2-3 kg) Chemicals required: Thiopental(15 mg /kg) Equipment required: Dental drill tooth pulp, clamping electrodes
  • 19.
  • 20. PRINCIPLE AND PROCEDURE • This method is based on the stimulation of the tooth-pulp of the animal by applying electric current. • Stimulation of the tooth-pulp produces characteristic reactions such as licking, biting, chewing and head flick due to induction of pain, which can be observed easily. • Rabbits of either sex are anaesthetized with 15 mg/kg thiopental or 0.2 mg/kg fentanyl-citrate i.v. • Pulp chambers are exposed close to the gingival line in the lateral margins of the two front upper incisors with a high- speed dental drill. • On the day of the experiment, clamping electrodes are placed into the drilled holes.
  • 21. • After an accommodation period of 30min, electrical stimulation is started to determine the threshold value. • The stimulus is applied by rectangular current with a frequency of 50 Hz for duration of 1 s. • The electrical current is started with 0.2 mA and increased until the phenomenon of licking occurs. • In some cases, the current has to be increased and then decreased again in order to find the appropriate threshold. EVALUATION • Test compound is administered orally or i.v . • After 15,30 60 and 120 min threshold current is measured and compared with the threshold current prior to drug administration.
  • 22. PAIN-STATE MODELS USING CHEMICAL STIMULI 4. ACETIC ACID INDUCED WRITHING TEST AIM • This test is used to screen analgesics by using chemical stimulus. REQUIREMENTS Animals required: Albino mice Chemicals required: Acetic acid 0.7% v/v (1ml/100g) Aspirin (100mg/kg)
  • 23.
  • 24. PRINCIPLE AND PROCEDURE • Pain is often induced in rats or mice by injecting certain irritants such as phenyl quinone or acetic acid into the peritoneal cavity. • The animal reacts with a characteristic stretching behavior which is called writhing. • The intra-peritoneal administration of agents that irritate serous membranes elicits a stereotyped behavior in the mouse/rat, which is characterized by abdominal contractions, movements of the body as a whole (particularly of the hind paws), twisting of dorso-abdominal muscles, and motor in- coordination. • Divide the animals into 2 groups each consisting of 5 animals. • The first group serves as control and the second group is the test group
  • 25. • Administer the appropriate volume of acetic acid solution to the first group and place individually under glass jar for observation. • Note the onset of writhing and number of writhing for a period of 10 minutes. • Administer Aspirin 100mg/kg orally to the second group of animals and 30 minutes later administer acetic acid solution. • Note the onset and number of writhing responses. EVALUATION • Calculating the mean writhing response of control and test group. • From this value the percentage protection of analgesics can be calculated.
  • 26. INVITRO METHOD 1. BIOASSAY OF NOCICEPTIN AIM • Nociceptin receptors in the periphery can be characterized by studies in isolated organs such as the guinea pig ileum, the mouse vas deferens, the rabbit vas deferens, the guinea pig renal pelvis. REQUIREMENTS Tissue : Guinea pig ileum, mouse vas deferens, rabbit vas deferens, guinea pig renal pelvis. Physiological salt solution: Kreb’s solution.
  • 27. PROCEDURE • Take the tissues from male Swiss mice, guinea pigs, Sprague Dawley rats & New Zealand albino rabbit. • Suspend in 10 ml organ baths containing Krebs solution oxygenated with 95% O2 & 5% CO2. • Set the temperature around 33°-37°C & apply 0.3-1g of resting tension. • Stimulate the tissue with two platinum ring electrodes. • Measure the electrically evoked contractions isotonically with a strain gauge transducer and record on a multichannel chart recorder.
  • 28. • After equilibration period of about 60 min the contractions induced by electrical field stimulation become stable; at this time, perform the cumulative concentration response curves to nociceptin or opioid peptides. • Perform four electrical field stimulation with each tissue at 30 min intervals. • Add Agonists & Antagonists to the bath. • The biological effects of the application of agonists or antagonists are expressed as % inhibition of electrical filed stimulation-induced contraction. • Contractile responses to electrical field stimulation are expressed as % increment to the spontaneous activity of the tissue.
  • 29. EVALUATION • Data are expressed as means of n experiments and statistically analyzed and recorded.
  • 30. 2. 3H- NALOXONE BINDING ASSAY AIM This test is used for the study of opiate agonist and antagonist. REQUIREMENTS Animal required: Wistar rat Physiological salt solution: Tris buffer
  • 31. PROCEDURE • Decapitate the male Wistar rat and rapidly remove their brain. • Weigh whole brain except cerebella and homogenize in 50ml of 0.05M Tris buffer with a Tekmar tissue homogenizer. • Centrifuge the homogenate for 15 minutes, decant the supernatant and re-suspend the pellet in fresh buffer and centrifuge. • Then suspend the final pellet in original volume of fresh 0.05M Tris buffer. • Incubate the tubes for 30 minutes at 37 degree Celsius.
  • 32. • The assay is stopped by vacuum filtration through Whatman GF filters which are then washed three times with ice-cold 0.05M Tris buffer of pH 7.7. • The filters are then counted in 10ml of Liquiscint liquid scintillation cocktail. • Stereospecific binding is defined as the difference between binding in presence of 0.1μM dextrorphan and 0.1μM levorphanol. EVALUATION • Data are converted into % stereospecific naloxone binding displaced by the test drug. • Data can be analyzed by using a computer program as described by McPherson in 1985.
  • 33. 3. INHIBITION OF ENKEPHALINASE AIM • It is found that the enkephalinase inhibitor thiorphan shows anti-nociceptive activity in mice. • So inhibition of enkephalinase is used as the invitro method for the screening of analgesics. REQUIREMENTS Animal required: Rat Physiological salt solution: Tris-HCl buffer
  • 34. PROCEDURE • Fresh rat kidney is homogenized in 10 vol of cold 0.05M Tris-HCl buffer of pH 7.4 using a Polytron homogenizer. • The homogenate is centrifuged for 5 minutes. • The pellet is discarded and the supernatant centrifuged for 60 minutes. • The resulting pellet is resuspended in 50mM Tris-HCl buffer and used as the enzyme source . • The assay is carried at 37 C in hemolysis tubes. • A 0.1ml amount of 50mM Tris-HCl buffer is preincubated 15 minutes at 37 C. • The reaction is initiated by addition of 50μl of the enzyme preparation together with 0.5 μM Captopril.
  • 35. • The tubes are incubated for 30 minutes in a water bath with constant shaking • The enzymatic reaction is stopped by boiling at 100 C for 5 minutes. • The samples are then diluted with 1.35ml of Tris-HCl buffer and centrifuged for 30 minutes. • 1ml of supernatant is transferred to thermostat cells of a spectrofluorometer. • Reading are performed at 562nm with an excitation wavelength of 342nm. • A calibration curve is prepared. EVALUATION • The inhibitory potencies of test compounds are compared with the standard.